Benchmark Botanics Inc. is a publicly traded company operating out of British Columbia, Canada, its common shares trade on the Canadian Securities Exchange (CSE) under the symbol “BBT”.
Benchmark cultivates and produces pharmaceutical grade medical and recreational cannabis, it has multi licenses under the Cannabis Act and its regulations (formerly ACMPR). The Company carries out its principal activities of cultivating and harvesting cannabis from its first facility in Peachland, BC., a 12,700 square foot indoor Peachland Cannabis Complex. The Company utilizes advanced cultivation methods and has established significant partnerships in the cannabis industry within Canada and overseas.
The Company prides itself on growing only the highest quality cannabis that meets and exceeds the requirements of the most stringent regulatory environments in the world. Benchmark vigorously follows industry best practices for cultivating, harvesting, curing, trimming and packaging, it uses only the highest quality seeds, nutrients and the state-of-the-art growing techniques in all production processes.
Benchmark can produce cannabis extracts using its state-of-the art supercritical fluid CO2 extraction technology. This process extracts the major cannabinoids (THC and CBD), as well as the minor cannabinoids, terpenes, and flavonoids that contribute to the overall medicinal value of medical cannabis, resulting in a highly concentrated resin. Benchmark can produce cannabis oil products with different ratios of THC and CBD.
Benchmark’s Peachland Cannabis Complex will be a 62,700 sq. ft operating space for future production of high-quality cannabis and cannabis products.